• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The putative mechanism of lymphopenia in COVID-19 patients.

作者信息

Wang Xinling, Liu Zezhong, Lu Lu, Jiang Shibo

机构信息

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.

Department of Infectious Diseases and Shenzhen Key Lab of Endogenous Infection, Shenzhen Nanshan People's Hospital and the Sixth Affiliated Hospital of Guangdong Medical University, Shenzhen 518052, China.

出版信息

J Mol Cell Biol. 2022 Aug 26;14(5). doi: 10.1093/jmcb/mjac034.

DOI:10.1093/jmcb/mjac034
PMID:35641108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9412754/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101a/9412754/8ebc8cfb25d2/mjac034fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101a/9412754/8ebc8cfb25d2/mjac034fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101a/9412754/8ebc8cfb25d2/mjac034fig1.jpg

相似文献

1
The putative mechanism of lymphopenia in COVID-19 patients.新冠病毒肺炎患者淋巴细胞减少的假定机制。
J Mol Cell Biol. 2022 Aug 26;14(5). doi: 10.1093/jmcb/mjac034.
2
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy.B细胞淋巴细胞减少症患者的重症新型冠状病毒肺炎及对恢复期血浆治疗的反应
J Clin Immunol. 2021 Feb;41(2):356-361. doi: 10.1007/s10875-020-00904-5. Epub 2020 Nov 20.
3
Host Response to Infection: Not All Lymphopenia Is Created Equal in SARS-CoV-2.宿主对感染的反应：在新冠病毒感染中，并非所有淋巴细胞减少都是一样的。
Am J Respir Crit Care Med. 2024 Feb 15;209(4):351-352. doi: 10.1164/rccm.202312-2265ED.
4
Potential impact of SARS-CoV-2 infection on the thymus.SARS-CoV-2 感染对胸腺的潜在影响。
Can J Microbiol. 2021 Jan;67(1):23-28. doi: 10.1139/cjm-2020-0170. Epub 2020 Jul 8.
5
Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [F]FDG PET/CT study.SARS-CoV-2 感染患者的淋巴细胞减少症是由大肠中淋巴细胞边缘堆积引起的：一项 [F]FDG PET/CT 研究。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3419-3429. doi: 10.1007/s00259-022-05801-0. Epub 2022 Apr 29.
6
Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.感染 SARS-CoV-2 的猕猴中出现短暂性淋巴细胞减少症和间质性肺炎伴内皮炎。
J Infect Dis. 2020 Oct 13;222(10):1596-1600. doi: 10.1093/infdis/jiaa486.
7
Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.淋巴细胞减少症预测 COVID-19 患者的疾病严重程度和恢复情况：一项单中心、回顾性研究。
PLoS One. 2020 Nov 18;15(11):e0241659. doi: 10.1371/journal.pone.0241659. eCollection 2020.
8
Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3CD8 T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission.根据 COVID-19 发病率统计数据的年龄分布对年龄队列进行分层，在入院时无合并症的 COVID-19 患者中识别出独特的与年龄相关的 CD3CD8 T 细胞淋巴细胞减少症。
Aging (Albany NY). 2021 Mar 10;13(6):7713-7722. doi: 10.18632/aging.202691.
9
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
10
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.SARS-CoV-2 诱导的急性呼吸窘迫综合征与髓系抑制细胞扩张、淋巴细胞功能障碍和精氨酸缺乏有关。
J Clin Immunol. 2021 Apr;41(3):515-525. doi: 10.1007/s10875-020-00920-5. Epub 2021 Jan 2.

引用本文的文献

1
Early lymphopenia as a predictor of COVID-19 outcomes: A multicenter cohort study.早期淋巴细胞减少作为COVID-19预后的预测指标：一项多中心队列研究。
Acute Med Surg. 2025 Mar 21;12(1):e70044. doi: 10.1002/ams2.70044. eCollection 2025 Jan-Dec.
2
Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching - Findings from the Multicenter LYMPH-COVID Study.新冠肺炎关键进展：通过倾向评分匹配揭示淋巴细胞减少症——多中心LYMPH-COVID研究的结果
Crit Care Sci. 2024 Sep 27;36:e20240236en. doi: 10.62675/2965-2774.20240236-en. eCollection 2024.
3
Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.

本文引用的文献

1
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.SARS-CoV-2 可在体外有效感染原代人免疫系统细胞，并在 COVID-19 患者体内感染。
J Mol Cell Biol. 2022 Aug 17;14(4). doi: 10.1093/jmcb/mjac021.
2
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation.FcγR 介导的 SARS-CoV-2 感染单核细胞激活炎症反应。
Nature. 2022 Jun;606(7914):576-584. doi: 10.1038/s41586-022-04702-4. Epub 2022 Apr 6.
3
ACE2-independent infection of T lymphocytes by SARS-CoV-2.SARS-CoV-2 对 T 淋巴细胞的 ACE2 非依赖性感染。
度普利尤单抗治疗急性中度至重度2019冠状病毒病1年后的肺功能和生存情况：一项2a期试验的随访研究
Open Forum Infect Dis. 2024 Jan 3;11(2):ofad630. doi: 10.1093/ofid/ofad630. eCollection 2024 Feb.
4
Tonsils are major sites of persistence of SARS-CoV-2 in children.扁桃体是新冠病毒在儿童体内持续存在的主要部位。
Microbiol Spectr. 2023 Sep 22;11(5):e0134723. doi: 10.1128/spectrum.01347-23.
5
Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19.在一项针对 COVID-19 住院患者的随机对照试验中，对托珠单抗反应的转录组学和蛋白质组学评估
iScience. 2023 Aug 11;26(9):107597. doi: 10.1016/j.isci.2023.107597. eCollection 2023 Sep 15.
Signal Transduct Target Ther. 2022 Mar 11;7(1):83. doi: 10.1038/s41392-022-00919-x.
4
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.奥密克戎变异株 B.1.1.529 对 SARS-CoV-2 的复制和致病性减弱。
Nature. 2022 Mar;603(7902):693-699. doi: 10.1038/s41586-022-04442-5. Epub 2022 Jan 21.
5
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.大规模单细胞转录组图谱揭示的 COVID-19 免疫特征。
Cell. 2021 Apr 1;184(7):1895-1913.e19. doi: 10.1016/j.cell.2021.01.053. Epub 2021 Feb 3.
6
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.严重急性呼吸综合征冠状病毒 2 诱导的单核细胞来源的人类巨噬细胞和树突状细胞的免疫激活和死亡。
J Infect Dis. 2021 Mar 3;223(5):785-795. doi: 10.1093/infdis/jiaa753.
7
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.CD147-刺突蛋白是 SARS-CoV-2 感染宿主细胞的新途径。
Signal Transduct Target Ther. 2020 Dec 4;5(1):283. doi: 10.1038/s41392-020-00426-x.
8
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2.严重急性呼吸综合征冠状病毒 2 的分离、序列、感染性和复制动力学。
Emerg Infect Dis. 2020 Sep;26(9):2054-2063. doi: 10.3201/eid2609.201495. Epub 2020 Jun 19.
9
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.新型冠状病毒肺炎患者支气管肺泡灌洗液和外周血单个核细胞的转录组学特征。
Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.